SCHEMBL5163953

SCHEMBL5163953

Cc1ccc(CN2C(=O)CC[C@H]2C(=O)N(Cc2ccccc2)[C@@H](Cc2c[nH]cn2)C(=O)O)cc1.O=C(O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCC(=O)N1Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 10/20 0.50
ITGA4 P13612 10/20 0.50
CAPN1 P07384 3/20 0.45
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP3A4 P08684 1/20 0.43
KMT2A Q03164 1/20 0.42
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
ALDH1A1 P00352 3/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7389323 0.92 CYP2C19 (0.44) ITGB1ITGA4CYP2C9CYP2C19CYP3A4
SCHEMBL5164311 0.87 CYP2C19 (0.44) ITGB1ITGA4CAPN1CYP2C9CYP2C19
SCHEMBL7391850 0.82 P2RX7 (0.41) ITGB1ITGA4CYP2C9CYP2C19KMT2A
SCHEMBL5165158 0.76 ITGB1 (0.74) ITGB1ITGA4CAPN1
SCHEMBL5164182 0.76 ITGB1 (0.74) ITGB1ITGA4CAPN1
SCHEMBL5165623 0.75 ITGB1 (0.57) ITGB1ITGA4CAPN1CYP2C9CYP2C19
SCHEMBL5161249 0.73 ITGB1 (0.80) ITGB1ITGA4CAPN1
SCHEMBL5683192 0.73 ITGA4 (0.68) ITGB1ITGA4CAPN1CYP2C9CYP2C19
SCHEMBL5693838 0.73 ITGB1 (0.70) ITGB1ITGA4CAPN1KMT2A
SCHEMBL6708108 0.72 ALDH1A1 (0.47) GAAALDH1A1TSHRKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763361-A2 STEROID SPARING AGENTS AND THEIR USE Elan Pharmaceuticals, Inc. (US) 2007-03-21 EP disclosed
WO-2005097162-A2 STEROID SPARING AGENTS AND THEIR USE ELAN PHARMACEUTICALS, INC. (US) 2005-10-20 WO disclosed